Latest Breaking News On - Institutional investors weigh in on eyepoint pharmaceuticals - Page 1 : comparemela.com

Analysts Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $34.00

Analysts Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $34.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Securities-exchange-commission
Hermes-inc
Insider-activity-at-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Franklin-resources-inc
Analyst-recommendations-for-eyepoint-pharmaceuticals
Nasdaq
Eyepoint-pharmaceuticals-price-performance
News-ratings-for-eyepoint-pharmaceuticals-daily
Jennison-associates
Jpmorgan-chase-co

StockNews.com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell

StockNews.com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Vanguard-group-inc
Hermes-inc
Eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Jennison-associates
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
Securities-exchange-commission
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-company-profile
Eyepoint-pharmaceuticals-stock-down
News-ratings-for-eyepoint-pharmaceuticals-daily

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:EYPT)

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:EYPT)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Switzerland
California
United-states
Essex
Swiss
Eyepoint-pharmaceuticals-inc
Insider-transactions-at-eyepoint-pharmaceuticals
Nasdaq
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
Proshare-advisors
Legacy-capital-group-california-inc

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Major Shareholder Cormorant Asset Management, Lp Buys 850,000 Shares of Stock

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Major Shareholder Cormorant Asset Management, Lp Buys 850,000 Shares of Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

China
Robertw-baird
Investment-advisers
News-ratings-for-eyepoint-pharmaceuticals-daily
Eyepoint-pharmaceuticals-price-performance
Securities-exchange-commission
Nasdaq
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
Proshare-advisors
Toth-financial-advisory-corp
Tower-research-capital

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa-paggiarino
Franklin-resources-inc
First-turn-management
News-ratings-for-eyepoint-pharmaceuticals-daily
Nasdaq
Eyepoint-pharmaceuticals
Securities-exchange-commission
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-inc
Eyepoint-pharmaceuticals-stock
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals